Thierry Hon

Besancon, 25030, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.

Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.

Journal: Clinical genitourinary cancer

Published: February 20, 2021

Systemic treatment of locally advanced or metastatic penile cancer

Systemic treatment of locally advanced or metastatic penile cancer

Journal: Bulletin du cancer

Published: July 05, 2020

Evaluation of Nurses' and Patients' Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR®): A French Observational Study.

Evaluation of Nurses' and Patients' Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR®): A French Observational Study.

Journal: Advances in therapy

Published: May 18, 2020

Radiotherapy of oligometastases: Sequences and interactions with systemic therapies, example of kidney cancer

Radiotherapy of oligometastases: Sequences and interactions with systemic therapies, example of kidney cancer

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: July 28, 2019

Targeted and immune therapies among patients with metastatic renal carcinoma undergoing hemodialysis: A systemic review.

Targeted and immune therapies among patients with metastatic renal carcinoma undergoing hemodialysis: A systemic review.

Journal: Seminars in oncology

Published: July 05, 2019

Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial.

Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial.

Journal: Trials

Published: January 17, 2018

Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice.

Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice.

Journal: Clinical genitourinary cancer

Published: July 11, 2017

Efficacy and Safety of Sequential Use of Everolimus in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Bevacizumab With or Without Interferon Therapy: Results From the European AVATOR Study.

Efficacy and Safety of Sequential Use of Everolimus in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Bevacizumab With or Without Interferon Therapy: Results From the European AVATOR Study.

Journal: Clinical genitourinary cancer

Published: June 27, 2014

Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma.

Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma.

Journal: OncoTargets and therapy

Published: March 07, 2014

Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma.

Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma.

Journal: Cancer chemotherapy and pharmacology

Published: January 30, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026